Skip to content

Comparison between Ratanhia peruviana and Individualized Homoeopathic Medicines in the treatment of Haemorrhoids in adults.

Effectiveness of Ratanhia peruviana versus Individualized Homoeopathic Medicines in the Management of Haemorrhoids in Adults: A Randomized Comparative Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/095600
Enrollment
68
Registered
2025-10-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K64- Hemorrhoids and perianal venous thrombosis

Interventions

Intervention1: Ratanhia peruviana: Participants in this group will receive Ratanhia peruviana. Administration of pill oral route in centesimal Scale. Pill size 30 no. First dose after case taking. R

Sponsors

Bakson Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All Genders aged between 18-59years Participants Clinically diagnosed with haemorrhoids by Digital Rectal Examination Participants willing to participate and give informed consent

Exclusion criteria

Exclusion criteria: Participants diagnosed with stage III stage IV internal haemorrhoids (prolapse haemorrhoids) Participants diagnosed with fissure fistula anorectal abscess and polyp of rectum Participants showing complication of haemorrhoids such as thrombosis gangrene and strangulation Pregnant and lactating mothers Participants with any psychiatric illness Participants diagnosed any severe systemic illness other immunocompromised conditions

Design outcomes

Primary

MeasureTime frame
To Compare The Changes in VAS Scale in Ratanhia peruviana Group and Individualized Homoeopathic Medicines Group.Timepoint: Total 16 months Enrollment period 6 months Follow up duration 6 months Data analysis 2 months Report writing 2 months Statistical data analyzed at baseline,at 12 weeks, 24 weeks

Secondary

MeasureTime frame
NILTimepoint:

Countries

India

Contacts

Public ContactDr Akshay Mathur

Bakson Homoeopathic Medical College and Hospital

manu0001sm@gmail.com767848833

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026